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Abstract
OBJECTIVE: To investigate the neuroprotective ef-
fects of Fructus Chebulae extract using both in vivo
and in vitromodels of cerebral ischemia.
METHODS: As an in vitro model, oxygen glucose
deprivation followed by reoxygenation (OGD-R)
and hydrogen peroxide (H2O2) induced cellular
damage in rat pheochromocytoma (PC12) cells was
used to investigate the neuroprotective effects of
extract of Fructus Chebulae. 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide assay
was used to calculate cell survival. For in vivo, occlu-
sion of left middle cerebral artery on rats was car-
ried out as a focal cerebral ischemic model.
RESULTS: Fructus Chebulae extract increases the
PC12 cell survival against OGD-R and H2O2 by 68%
and 91.4% respectively. Fructus Chebulae also de-
creases the cerebral infarct volume by 39% and ex-
tent of hemisphere swelling from 17% in control
group to 10% in Fructus Chebulae treated group.
CONCLUSION: Fructus Chebulae, as a traditional
medicine, can rescue the neuronal cell death
against ischemia related damage. The possible
mechanism for the neuroprotection might be the
inhibition of oxidative damages occurring after
acute phase of cerebral ischemia.
© 2014 JTCM. All rights reserved.
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INTRODUCTION
Cerebral ischemic stroke is recognized as the most com-
mon reason of disability in old age and is the common
cause of death worldwide.1 A number of neuroprotec-
tive compounds, such as calcium channel inhibitors,
antagonists of glutamate receptor, free radical scaveng-
ing agents, anti-inflammatory agents, nitric oxide syn-
thase inhibitors etc., have been suggested for their ther-
apeutic potential in stroke patients.2 However, though
these drugs have been found to be effective in experi-
mental studies, they have shown mixed efficacy in hu-
man clinical trials. Currently practiced pharmacologi-
cal therapy for stroke patient is ineffective and that
leads to the search for newer pharmacologic approach-
es.3 Because of the absence of effective and commonly
applicable pharmacological agent for stroke treatment,
traditional medicines, mainly of herbal origin, are at-
tracting attention.4 In this regards, we have been screen-
ing several medicinal plants for their possible protec-
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tive effects in cerebral ischemia/stroke, and among
such plants, Fructus Chebulae, a well-known medicinal
plant in Ayurveda, showed the promising effects.
In Ayurveda, Fructus Chebulae is commonly used as
cardiotonic, digestive, diuretic, antitussive, antidiabet-
ic, and laxative.5,6 Fructus Chebulae was previously re-
ported to have antioxidant7,8 anticancer,9 antidiabetic,10
anti-hyperglycemic,11 antimutagenic,12 anti-ulcer,13 hep-
atoprotective,14 cytoprotective15 and cardio-protective
activities.16 Major phytochemicals reported from fruit
are chebulic acid, chebulagic acid, ellagic acid, querce-
tin, gallic acid, corilagin, rutin, casuarinin, tannic acid,
etc.7,17,18 Recently, Fructus Chebulae and its phytochemi-
cals, have been reported to possess strong antioxidant
and anti-inflammatory effects.
In spite of the abundant evidence supporting the anti-
oxidant and anti-inflammatory effects of Fructus Cheb-
ulae, and its active polyphenols; few in vitro researches
have been reported about the neuroprotective effect of
Fructus Chebulae. However, the neuroprotective poten-
tials of Fructus Chebulae extract using in vivo ischemic
models have not been reported yet. In present study,
the neuroprotective activity of Fructus Chebulae ex-
tracts was investigated in experimental ischemic mod-
els. We used rat pheochromocytoma (PC12) cell line
treated with oxygen glucose deprivation followed by re-
oxygenation (OGD-R) and hydrogen peroxide (H2O2)
as an in vitro model. For in vivo, occlusion of middle
cerebral artery (MCAo) induced focal cerebral isch-
emia models in rats was used.
MATERIALS ANDMETHODS
Extraction and sample preparation
After proper identification by the experts and literature
comparison, Fructus Chebulae were purchased from Na-
tional Exports Private Limited (Kathmandu, Nepal). A
herbarium and voucher specimen (HP203) was pre-
served in the College of Korean Medicine, Kyung Hee
University, Seoul, South Korea. Total 100 g of Fructus
Chebulae was grinded and powder (100 g) was extract-
ed using 70% methanol (1000 mL) under reflux con-
denser (Sigma Chemical Co., St. Louis, MO, USA).
The organic solvent of extracts was then evaporated
and lyophilized until complete dryness. The yield value
of extract was found as 36.48%.
OGD-R induced cell injury
OGD-R experiment was performed as described previ-
ously.19 Briefly, PC12 cells at a density of 1.5×103 cells/
well were seeded and cultured at 37℃ . Dulbecco's
Modified Eagle Medium (DMEM) containing 10%
heat-inactivated fetal bovine serum (FBS), 1×105 U/L
penicillin and 100 mg/L streptomycin (Gibco BRL,
Grand Island, NY, USA) in a 5% CO2 incubator was
used as culture medium. OGD-R was performed at 24
h after the cell seeding. PC12 cells were first washed
with phosphate buffer saline (PBS) followed by glu-
cose-free DMEM. Then fresh glucose free DMEM was
placed in cultures and kept in a hypoxic chamber (For-
ma Science, UK) containing 5% CO2 and 95% N2 for
4 h. After 4 h, fresh glucose solution was added, and
the cells were incubated in a 5% CO2 incubator at
37℃ for 24 h. PC 12 cells were treated with different
concentrations of Fructus Chebulae extracts (at 0.1, 1,
10 μg/mL) 30 min before and during OGD period. Se-
rum free glucose DMEM of same amount was used for
the control group. For positive control, Baicalein, a
well-known neuroprotective and antioxidative com-
pound20 was used.
H2O2 induced cell injury
Prior to each experiment, H2O2 was diluted from stock
solution (30%) using DMEM. For H2O2 induced cell
injury, cultured PC12 cells were first washed with FBS
free DMEM and treated with 200 μM H2O2 solution
and incubated 24 h. Different concentrations of Fruc-
tus Chebulae extracts were treated 2 h before and dur-
ing H2O2 exposure period. Control group were not
treated with H2O2, however incubated under the same
conditions.
Animals and MCAo surgery
All animal handling and surgical procedures were per-
formed in compliance with animal welfare guidelines
of Korean Academy of Medical Sciences and the Na-
tional Institutes of Health (NIH). Male Sprague-Daw-
ley rats [(300 ± 5) g, 8 weeks], were purchased from
Samtako, Gyeonggi-do, Korea. Before experimental
procedure, rats were acclimatized in controlled condi-
tions of temperature (22℃ ± 2℃ ), relative humidity,
and a 12 h light/dark cycle, with free access of food
and water.
Rats were ventrally fixed in operating frame and anes-
thetized with isoflurane in N2O∶O2 (3∶1). The body
temperature was controlled and maintained at 37.0℃±
0.5℃ during the experimental procedure with rectal
thermistor connected with a heating blanket (Harvard
Apparatus, Holliston, MA, USA). Focal cerebral isch-
emia was induced using the modified methods of intra-
luminal suture occlusion.21 After 90 min of MCAo peri-
od, the suture was carefully removed and reperfusion
was allowed for 24 h. Body temperature was main-
tained at 37.0℃±0.5℃ , till the 6.5 h after occlusion.
For the sham operated group, similar surgical proce-
dure was done but the MCA was not occluded.
Drug treatment
Animals were randomly divided into 4 different
groups; sham, control, and 2 extract treated groups
(300 and 500 mg/kg). Different concentration of Fruc-
tus Chebulae extracts was dissolved in 5% dimethylsulf-
oxide (DMSO) and orally administered immediately af-
ter MCA occlusion (0 min). The doses of Fructus Cheb-
ulae extracts (determined based on the previous experi-
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ment during screening) were 300 and 500 mg/kg per
5 mL, administered orally, whereas 5% DMSO was ad-
ministered to the control group.
Tissue preparation and infarct volume measurement
Twenty four hours after the ischemia induction, rats
were sacrificed; the brain was removed quickly and
sectioned into 2 mm thick coronal sections. Brain
slices were then stained using 2% 2,3,5-triphenyltet-
razolium chloride (TTC) in distilled water at 37℃ .
TTC stained slices were photographed, and brain in-
farct area were examined by a computerized image
analysis system (Optimas, Media Cybernetics, MD,
USA). Infarct volume in ipsilateral hemisphere was
calculated by multiplying the infarct area with the
thickness of the section and correlated infarct volume
(%) was calculated.
Hemispheric swelling index (cerebral edema)
To evaluate the degree of cerebral hemispheric swell-
ing, volumes of contralateral and ipsilateral hemi-
spheres was measured using Image Proplus software ver-
sion 5.1 (Media Cybernetics, Silver Spring, MD,
USA). The brain edema volume was then expressed as
a percentage of the normal volumes in the contralateral
hemisphere as described by22 using the following for-
mula:
Extent of Edema =
Volume of IH- volume of  CH
Volume of CH
X 100%
Where IH is ipsilateral (infarct) hemisphere and CH is
contralateral (unaffected) hemisphere
Statistical analysis
All results were expressed as mean±standard deviation.
Differences between control and each experimental
groups were compared using t-test, whereas multiple
differences between groups were compared using one
way analysis of variance (ANOVA) followed by the
Tukey's Post Hoc test. Statistical tests were performed
using GraphPad Prism 4 (GraphPad Software Inc., La
Jolla, CA, USA). P<0.05 was considered as statistically
significant for the experimental analysis compared with
the control groups.
RESULTS
Fructus Chebulae extract protects PC12 cells from
OGD-R induced damage
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium
bromide (MTT) assays was used to determine the sur-
vival of cells after treatment of Fructus Chebulae ex-
tract. At different concentration (0.1-10 μg/mL), Fruc-
tus Chebulae didn't show the cytotoxic effects on cul-
tured PC12 cells indicating that it is safe for cellular ex-
periment. To study the protective effect of Fructus Cheb-
ulae extract afterOGD-R induced damage, Fructus Cheb-
ulae extracts were treated 30 min before and during 4 h
of OGD period. Cell density in OGD group was signif-
icantly reduced (50.1%±1.1%) whereas in Fructus Cheb-
ulae extract treated groups (at 0.1, 1, 10μg/mL) cell sur-
vival was found as 62.5%±2.2%, 68.1%±2.7%, and
55.8%± 1.9% respectively, all P<0.05 as compared to
that of control group (set as 100%). Baicalein, used as
positive control, at 0.27 μg/mL (1 μM) showed
74.5%±2.9% cell viability (Figure 1).
Fructus Chebulae extract protects PC12 cells from
H2O2 induced oxidative damage
We next determined the protective effect of Fructus
Chebulae extract on H2O2 induced oxidative damage in
PC12 cells. H2O2 showed the concentration and
time-dependent toxicity in PC12 cells (data not
shown). Concentration of H2O2 used was 200 μM for
and it was determined based on the toxicity study.
H2O2 treated group showed the cell viability of 71.4%±
1.3% whereas that in Fructus Chebulae extract treated
groups were 81.6% ± 3.8% (0.01 μg/mL), 91.3% ±
3.7% (0.1 μg/mL), and 86.8%±4.2% (1 μg/mL) re-
spectively, all P<0.05 as compared to that of control
group (set as 100% ). Baicalein, used as positive con-
trol, treated cells showed 83.8%±2.5% (0.27 μg/mL)
cell viability against H2O2 (Figure 2).
Fructus Chebulae extracts reduce the infarct volumes
and cerebrovascular edema in rats
Fructus Chebulae extracts significantly reduced the
brain infarct volume after 90 min of MCAo followed by
24 h reperfusion. The representative TCC stained brain
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Figure 1 Protective effect of Fructus Chebulae extracts in
PC12 cells exposed to OGD-R
A: control; B: OGD-R; C: Fructus Chebulae (0.1 μg/mL); D: Fruc-
tus Chebulae (1 μg/mL); E: Fructus Chebulae (10 μg/mL); F: Ba-
icalein (0.27 μg/mL). PC12 cells were treated with OGD for 4
h and re-oxygenated for 24 h. PC12 cells were treated with
Fructus Chebulae extracts at different concentrations at 30
min before and 4 h of OGD period. Cell viability in control
group was set as 100% , and cell densities in other experi-
mental groups were shown as percentage of control.
OGD-R: reoxygenation. aP<0.01, bP<0.001, and cP<0.05 as
compared to the OGD-R group.
Experimental groups
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section photographs are shown in Figure 3A. The in-
farct volume of rats, consuming 500 mg/kg of Fructus
Chebulae extracts (207.105mm3) was found to be signifi-
cantly lower than that in control (vehicle) treated group
(388.932 mm3) (P<0.05). The extracts at 500 mg/kg
showed the 39% reduction of infarct volume, whereas
that of 300 mg/kg was 32% (Figure 3B). Effect of Fruc-
tus Chebulae on extent of hemisphere swelling are
shown in Figure 3C.
DISCUSSION
As in the ischemic conditions, OGD-R increases the
formation of free radicals, produce from different
sources such as inflammatory cytokines, glutamate tox-
icity etc.23,24 Overproduction of free radicals in the cells
are believed to be the key mediators of tissue damage
after ischemia-reperfusion in animal models25 and as
OGD-R mimics the tissue ischemia similar cellular
events occur in PC12 cells as well. Cellular damage af-
ter ischemia reperfusion is a very complex pathophysio-
logical condition, which is associated with impairment
of several cellular and vascular responses. Oxidative
stress induced by reactive oxygen species (ROS) and re-
active nitrogen species (RNS) play the crucial role to
initiate a wide ranges of intracellular signaling process-
es that results in excessive cytokine and chemokine re-
sponse which ultimately leads to the cellular death.26
Once the ROS and RNS are generated in the cells, vari-
ous oxidative cascades take place simultaneously, in-
cluding free radical production, excitotoxicity, enzymat-
ic alterations, sudden start and aggravation of mito-
chondrial respiratory chains and stimulation of the in-
flammatory processes.27 Among such oxidative cas-
cades, damage due to free radicals and inflammation
are the key factor for the cellular damage. Therefore,
phytochemicals having strong anti-inflammatory, anti-
oxidant, anti-glutamate properties can antagonize the
cytotoxic effects of free radicals and protect the cells
against hypoxia induced damage.24,28-30
In this study, Fructus Chebulae extract significantly pro-
tected the OGD-R exposed PC12 cells. The 4 h of
OGD exposure and 24 h of re-oxygenation leads to the
significant damage in PC12 cells compared to that of
control cells. Treatment of PC12 cells with Fructus Che-
bulae extract at different concentration, 30 min before
followed by 4 h during the OGD period, significantly
increases the cell survival. OGD facilitates the cytotox-
icity in the cells by activating the cascades of oxidative
events such as nuclear factor-κB, lipoxygenase, IκB ki-
nase, suggesting that OGD-R acts as the major source
of free radical in ischemic conditions.31,32 In present
study, Fructus Chebulae extract significantly seques-
Figure 1 Effect of Fructus Chebulae extracts on reducing the infarct volumes and cerebrovascular edema in rats
A: representativeTCC-stained brain slices after 90min ofMCAo, and 24 h of reperfusion. Photographs are coronal brain slices stained
with TTC 24 h after ischemia showing infarct area (white) and intact area (red). B: effect of Fructus Chebulae in infarct volume after
MCAo.C:effectofFructusChebulaeonextentofhemisphereswelling.Ⅰ: Sham;Ⅱ: control;Ⅲ:FructusChebulae (300 mg/kg);Ⅳ: Fruc-
tus Chebulae (500 mg/kg). TTC: 2,3,5-triphenyltetrazolium chloride; MCAo: middile cerebral artery. aP<0.01, compared to the con-
trol (vehicle) treated group.
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Figure 2 Protective effect of Fructus Chebulae extract on
H2O2-induced PC12 cell death
A: control; B: H2O2; C: Fructus Chebulae (0.01 μg/mL); D: Fruc-
tus Chebulae (0.1 μg/mL); E: Fructus Chebulae (1 μg/mL); F:
Baicalein (0.27 μg/mL). PC12 cells were treated with 200 μM
H2O2 for 24 h. Fructus Chebulae extracts were treated 2 h be-
fore and during H2O2 exposure period. Cell density in control
group (without H2O2) was set as 100%, and data obtained in
other groups were expresses as percentage of control
group. aP<0.05, bP<0.001, and cP<0.01 as compared to the
OGD-R group.
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tered the DPPH free radicals and the strong antioxi-
dant efficacy of Fructus Chebulae extract might acts as
the key role for ROS sequestering, which are in the
ischemic conditions, like OGD-R and protects the
cells from damage.
Fructus Chebulae extract significantly protects
(91.52%) the PC12 cell from H2O2 induced oxidative
damage, and the protective effect of extracts was found
to be higher than that of potent antioxidant com-
pound, baicalein (84.02% ). H2O2 itself is not a free
radical and has a limited reactivity; however, it is be-
lieved to be the major precursor of the highly reactive
hydroxyl radical. Previous studies have reported the in-
timate association between neurodegenerative disease
and H2O2, and it has been advised that levels H2O2 is
increased during various pathological conditions, such
as ischemia.33,34 Reactive oxygen species, such as H2O2,
readily damage several biomolecules that can eventual-
ly lead to apoptotic or necrotic cell death.35 In this
study, the protective effect of Fructus Chebulae extract
was not concentration dependent. Interestingly, the
cell viability in Fructus Chebulae extract treated group
was higher in less concentration of Fructus Chebulae ex-
tract and lower in higher concentration. Gallic acid,
quercetin, and ellagic acids are the major polyphenolic
compounds from Fructus Chebulae and they are
well-known antioxidant. These polyphenols are previ-
ously reported to have pro-oxidant activity at higher
concentrations36,37 and such properties of Fructus Cheb-
ulae polyphenols might explain the lesser protective ef-
fect of Fructus Chebulae extract at higher concentration.
After MCAo induced focal cerebral ischemia, the acute
phase damage occurs in ischemic core that consists of
the parietal somato-sensory cortex and lateral portion
of the caudate putamen.21 The region around the isch-
emic core, penumbra, undergoes slow tissue damage af-
ter several hours of ischemic induction. The penum-
bral tissue damage can be protected by preventing the
cell death processes using neuroprotective agents.38 The
neuroprotection in ischemic core is almost impossible
and penumbra is the target of therapeutic efforts in the
acute phase of ischemia or stroke.39 Fructus Chebulae
treatment (500 mg/kg) reduced the brain damage in
penumbra, and the infarct area was limited to part of
the caudate putamen and parietal cortex, which is be-
lieved to be the ischemic core.40 Therefore, these results
suggest that Fructus Chebulae can protect neuronal cells
in the penumbra region and it can act as a potential
neuroprotective agent in stroke. As shown in figure
3C, the extent of hemispheric swelling in extracts treat-
ed group at higher dose (500 mg/kg), was significantly
lower than that of vehicle treated group. Generally, ce-
rebral edema is determined through calculating the wa-
ter content by subtracting the weight of dry brain from
the weight of wet brain.41,42 However, in this study, we
relatively calculated the extent of edema to measure the
hemisphere swelling index as described.22
Previous studies established the correlations between
neurological deficit after MCA occlusion and the ex-
tent of cerebral edema as estimated by hemispheric en-
largement.43 Cerebrovascular edema after ischemic in-
sult appears to contribute severely to morbidity and
mortality in stroke patient.44 Following cerebral isch-
emia/stroke swelling of damaged cells, leaking of in-
jured blood vessels occurs that subsequently block the
absorption pathways forcing fluid to enter brain tis-
sues. Cytotoxic edema which is developed in response
to the occlusion of large MCA is a major clinical prob-
lem45,46 and it has been associated with about 80% mor-
tality rate in stroke patient. Occlusion of cerebral ves-
sels initiates a sequence of events involving cell swell-
ing, followed by blood brain barrier leakage and tissue
hemorrhage.47 Activated microglia play pivotal role to
produce various pro-inflammatory cytokines such as
IL-6, TNFα, IL-1β, and also anti-inflammatory cyto-
kines such as IL-10, IL-4, and TGFβ, contributing the
cerebrovascular edema.48 Fructus Chebulae is reported
to have strong inhibitory effeect against inflammatory
chemokine, IL-849 and NF-κB, mediator of cellular in-
flammation50 suggesting that it can prevent the secre-
tion of inflammatory mediators through the activated
microglia after stroke. In our study, the hemisphere
swelling index in rats treated with 500 mg/kg of Fruc-
tus Chebulae extracts was significantly lower than that
in vehicle treated group.
In summary, Fructus Chebulae extract showed the sig-
nificant protective effect against in vitro OGD-R and
H2O2 induced cell death. It also has protective effect
against neuronal cell death on MCAo/reperfusion in-
duced cerebral ishcemic injury, suggesting that it can
act the potential herbal medicine, to treat cerebral isch-
emia and related diseases.
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